One of the most frequently asked questions regarding Selank is whether there is an ideal time of day for its administration. Currently, the scientific literature does not indicate a universally recommended dosing schedule. Most studies have focused on the effects of Selank on anxiety, stress resistance, cognitive function, neurochemistry, and brain function, rather than on determining the optimal time of administration [1–4].
As a result, researchers did not identify a specific morning, afternoon, or evening pattern that consistently provided better effects. The most appropriate time of use may depend on the research objective, such as supporting cognitive functions, regulating emotions, or managing stress. Those seeking information on the phrase „when to take Selank” should be aware that current scientific data does not indicate one best time of day.
What Time of Day Should Selank Be Used?
Current research suggests that the timing of Selank administration is primarily dependent on the intended purpose, rather than a biologically confirmed need for a specific time of day.
Research suggests that Selank affects several neurobiological systems, including GABAergic signalling, enkephalin metabolism, neurotrophic factors such as BDNF (brain-derived neurotrophic factor), and immune system-related pathways [2–5]. However, available data do not indicate that these mechanisms are strongly linked to a specific time of day.
Unlike some peptides related to growth hormone secretion or sleep physiology, Selank has been studied primarily for its anxiolytic, neuroprotective and neuroregulatory effects. For this reason, published studies do not provide strong evidence that morning use is better than evening use or vice versa.
Can Selank Be Used in the Evening?
Current scientific literature does not suggest that using Selank in the evening is problematic. On the contrary, some researchers indicate that its effect on stress regulation and emotional balance may support a calmer mental state in the evening hours [2,4].
Crucially, Selank does not act as a classic stimulant. Clinical studies conducted on individuals with generalised anxiety disorder have shown a reduction in anxiety symptoms without excessive arousal, restlessness, or overstimulation [1]. Animal studies have also demonstrated anxiolytic effects without the marked sedation characteristic of benzodiazepines [6].
As Selank appears to support balance within several neurotransmitter systems, the available data do not indicate that evening use would be inappropriate.
Selank Before Bed
Although research directly addressing the impact of Selank on sleep is limited, current data do not indicate that it negatively affects normal sleep physiology. Some proposed mechanisms of action, such as stress reduction and emotional regulation, may theoretically support pre-sleep relaxation [2,4].
However, it is worth emphasising that Selank was not developed as a sleep-inducing peptide. Most research focuses on anxiety, cognitive function, neuroprotection, and neurochemical regulation, rather than insomnia or sleep disorders [1–5].
For this reason, there is currently insufficient evidence to recommend the use of Selank solely to improve sleep quality.
Does Selank Require Refrigeration?
How to Store Selank?
Correct storage is essential for maintaining peptide stability. Like many other peptide compounds, Selank can degrade under the influence of high temperatures, light, moisture, and significant temperature fluctuations.
The majority of scientific research concerning Selank concentrates on its biological activity rather than storage conditions. Consequently, the scientific literature does not establish a single universal storage standard suitable for all formulations [1–5].
Storage requirements can depend on several factors:
- Does the peptide come as a freeze-dried powder or a ready-made solution?.
- Applied formulation and excipients.
- Manufacturer or research supplier.
- The planned storage period.
For these reasons, researchers usually follow instructions for specific products.
Should Selank be stored in the refrigerator?
Scientific literature does not present a single universal recommendation regarding the storage of all products containing Selank. However, in peptide research, refrigeration is a common practice, as lower temperatures help to slow down the degradation process and support the stability of the preparation.
Freeze-dried peptides and reconstituted peptide solutions often exhibit different stabilities, therefore, storage recommendations may vary depending on the product form.
Since there are no standardised storage protocols in the literature, the manufacturer's guidelines remain the most reliable source of information.
Does the nasal spray with Selank require refrigeration?
Research confirms that Selank retains biological activity after intranasal administration, however, available publications do not specify standardised storage conditions for nasal spray preparations [3,4].
Nasal preparations often contain additional ingredients such as buffers, stabilisers, preservatives, and solvents. These can significantly affect the product's shelf life and storage requirements.
As formulations differ, recommendations for storing sprays should be based on the manufacturer's instructions for the specific product.
Storing Reconstituted Selank
The available literature does not contain controlled stability studies assessing the shelf-life of reconstituted Selank solutions.
Once the peptide has been dissolved in a liquid, factors such as the risk of contamination, oxidation, hydrolysis, and temperature sensitivity become more significant. For this reason, ready-made solutions often require more stringent storage conditions than the dry powder.
As there is currently no generally accepted stability data, the manufacturer's recommendations for the specific formulation should be followed.
What is the half-life of Selank?
Is the half-life of Selank known?
One of the most frequently asked questions about Selank is its half-life. Despite a large number of studies on the biological activity of this peptide, no pharmacokinetic studies in humans have yet been published that clearly define its plasma half-life, blood concentration profile, or exact elimination time [2–5].
Most research has focused on effects such as anxiety reduction, neuroprotection, neurotransmitter regulation, BDNF expression, and impact on gene expression, rather than pharmacokinetic measurements.
Why is it Difficult to Determine the Half-Life of Selank?
Selank is a synthetic heptapeptide with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed to have greater stability than its natural precursor, tuftsin, due to the addition of the Pro-Gly-Pro fragment [5].
Although this modification increases resistance to enzymatic degradation, it does not automatically determine the persistence of the peptide in circulation. Accurately establishing the half-life requires specialised pharmacokinetic studies monitoring blood concentration over time, and such studies are currently lacking.
How long does Selank stay in the body?
Without formal pharmacokinetic data, it is impossible to accurately determine how long Selank remains detectable in the body.
It is also necessary to distinguish between the physical presence of the peptide and the duration of its biological effects. Studies suggest that Selank may initiate processes related to GABA receptor modulation, enkephalin metabolism, BDNF regulation, and gene expression, which may persist even after the peptide itself has been metabolised [2–5].
As a result, the biological duration of action may be longer than the period of the peptide's presence in circulation.
How long does Selank last?
Although the exact half-life remains unknown, several studies suggest that Selank may induce measurable biological effects beyond the immediate period of administration.
Animal studies have demonstrated a sustained reduction in anxiety-related behaviours during multi-week administration [6]. Other work has documented long-lasting changes in neurotransmitter systems, gene expression, and neurotrophic pathways following intranasal administration of Selank [2–4].
These results suggest that Selank's biological effects may persist longer than the peptide itself remains in the bloodstream, although the exact duration has yet to be determined.
Summary
Current scientific data do not indicate a single optimal time of day for Selank administration. Studies suggest that the choice of administration time depends more on the intended purpose than on any specific biological requirement. Both morning, afternoon, and evening use have been discussed, but no regimen has shown a clear advantage.
Similarly, although Selank was designed to be more stable than tuftsine, its precise half-life and elimination time remain unknown due to a lack of dedicated pharmacokinetic studies. However, it is known to affect multiple neurobiological systems and can cause effects that last longer than the peptide's presence in circulation.
Disclaimer
This material is for educational and informational purposes only. Selank remains a research peptide in many countries, and many aspects concerning its pharmacokinetics, storage stability, and optimal administration timing have not yet been fully characterised in large human clinical trials.
For research purposes only: Selank products supplied by Semax Polska are intended solely for laboratory and scientific research. They are not approved for human consumption, medical use, diagnosis, treatment or the prevention of disease. All research materials should be used in accordance with applicable regulations and the principles of good laboratory practice.
References
[1] Zozulia, A. A., Neznamov, G. G., Siuniakov, T. S., Kost, N. V., Gabaeva, M. V., Sokolov, O. Y., Serebriakova, E. V., Siranchieva, O. A., Andriushenko, A. V., Telesheva, E. S., Siuniakov, S. A., Smulevich, A. B., Myasoedov, N. F., & Seredenin, S. B. (2008). Efficacy and Possible Mechanisms of Action of a New Peptide Anxiolytic Selank in the Therapy of Generalised Anxiety Disorders and Neurasthenia. Journal of Neurology and Psychiatry named after S.S. Korsakov, 108(4), 38–48. https://pubmed.ncbi.nlm.nih.gov/18454096/
[2] Vyunova, T. V., Andreeva, L., Shevchenko, K., & Myasoedov, N. F. (2018). Peptide-Based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. Protein and Peptide Letters, 25(10), 914–923. https://doi.org/10.2174/0929866525666180925144642
[3] Levitskaya, N. G., Andreeva, L. A., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Intranasal Administration of the Peptide Selank Regulates BDNF Expression in the Rat Hippocampus In Vivo. Doklady Biological Sciences, 431, 79–82.
[4] Andreeva, L. A., Nagaev, I. Y., Mezentseva, M. V., Shapoval, I. M., Podchernyaeva, R. Y., Shcherbenko, V. E., Potapova, L. A., Russu, L. I., Ershov, F. I., & Myasoedov, N. F. (2010). Antiviral Properties of Structural Fragments of the Peptide Selank. Doklady Biological Sciences, 431, 79–82. https://doi.org/10.1134/S0012496610020031
[5] PubChem. (2026). Selank (CID 11765600). National Centre for Biotechnology Information. https://pubchem.ncbi.nlm.nih.gov/compound/11765600
[6] Czabak-Garbacz, R., Cygan, B., Wolański, Ł., & Kozlovsky, I. (2006). Influence of Long-Term Treatment with Tuftsin Analogue TP-7 on Anxiety-Phobic States and Body Weight. Pharmacological Reports, 58(4), 562–567. PMID: 16963804.